Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula

NCT02425423 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

United Pharmaceuticals